Total Payments
$4,082
2024 Payments
$625.84
Companies
23
Transactions
67
Medicare Patients
25,251
Medicare Billing
$18.7M
Payment Breakdown by Category
Food & Beverage$2,605 (63.8%)
Travel$1,083 (26.5%)
Education$270.78 (6.6%)
Other$122.74 (3.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,605 | 61 | 63.8% |
| Travel and Lodging | $1,083 | 3 | 26.5% |
| Education | $270.78 | 2 | 6.6% |
| Entertainment | $122.74 | 1 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Penumbra, Inc. | $1,650 | 4 | $0 (2021) |
| Genentech USA, Inc. | $320.18 | 11 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $307.22 | 11 | $0 (2024) |
| Medtronic Vascular, Inc. | $256.12 | 1 | $0 (2019) |
| Apellis Pharmaceuticals, Inc. | $200.78 | 8 | $0 (2024) |
| Abbott Laboratories | $145.48 | 1 | $0 (2021) |
| Alcon Laboratories Inc | $145.14 | 1 | $0 (2017) |
| ABBVIE INC. | $140.93 | 6 | $0 (2024) |
| Optos, Inc. | $122.74 | 1 | $0 (2017) |
| Allergan Inc. | $119.23 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $625.84 | 22 | Regeneron Healthcare Solutions, Inc. ($175.40) |
| 2023 | $184.65 | 8 | Apellis Pharmaceuticals, Inc. ($55.00) |
| 2022 | $201.08 | 8 | Regeneron Healthcare Solutions, Inc. ($64.44) |
| 2021 | $1,903 | 7 | Penumbra, Inc. ($1,650) |
| 2019 | $555.86 | 8 | Medtronic Vascular, Inc. ($256.12) |
| 2018 | $98.61 | 4 | Novartis Pharmaceuticals Corporation ($45.93) |
| 2017 | $512.22 | 10 | Alcon Laboratories Inc ($145.14) |
All Payment Transactions
67 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 11/18/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/13/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: EYE CARE | ||||||
| 11/07/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $35.43 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/06/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Ophthalmology | ||||||
| 10/30/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $33.83 | General |
| Category: Ophthalmology | ||||||
| 10/23/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $39.86 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/08/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: Ophthalmology | ||||||
| 09/26/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $32.49 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/25/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/18/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $34.25 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/14/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $34.09 | General |
| Category: Ophthalmology | ||||||
| 06/12/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $33.17 | General |
| Category: Ophthalmology | ||||||
| 05/29/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: Ophthalmology | ||||||
| 05/15/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/25/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $38.11 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/17/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $25.48 | General |
| Category: EYE CARE | ||||||
| 03/06/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: EYE CARE | ||||||
| 02/28/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: EYE CARE | ||||||
| 02/21/2024 | Coherus Biosciences Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $27.01 | General |
| Category: Ophthalmology | ||||||
| 02/14/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $26.72 | General |
| Category: Ophthalmology | ||||||
| 01/31/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/13/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/09/2023 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: EYE CARE | ||||||
| 09/19/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $28.68 | General |
| Category: Immunology and Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 6,672 | 189,779 | $16.8M | $7.6M |
| 2022 | 23 | 6,732 | 49,939 | $12.9M | $4.9M |
| 2021 | 16 | 6,019 | 22,557 | $10.1M | $3.6M |
| 2020 | 21 | 5,828 | 20,720 | $8.0M | $2.7M |
Total Patients
25,251
Total Services
282,995
Medicare Billing
$18.7M
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 368 | 170,347 | $8.5M | $4.9M | 57.9% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 155 | 1,949 | $2.9M | $1.3M | 45.4% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 1,798 | 5,648 | $2.2M | $551,262 | 25.4% |
| 67028 | Injection of drug into eye | Office | 2023 | 603 | 3,917 | $1.6M | $381,662 | 23.5% |
| 92134 | Imaging of retina | Office | 2023 | 1,990 | 5,560 | $689,356 | $172,504 | 25.0% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 186 | 715 | $127,050 | $50,641 | 39.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 513 | 545 | $212,005 | $36,445 | 17.2% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 279 | 279 | $127,224 | $30,921 | 24.3% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 28 | 28 | $96,628 | $25,450 | 26.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 147 | 147 | $73,500 | $15,615 | 21.2% |
| 92250 | Photography of the retina | Office | 2023 | 355 | 379 | $45,480 | $10,590 | 23.3% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 96 | 97 | $34,629 | $10,213 | 29.5% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2023 | 12 | 12 | $32,520 | $8,558 | 26.3% |
| 67210 | Destruction of growth of retina using a laser | Office | 2023 | 18 | 19 | $27,550 | $7,486 | 27.2% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 34 | 36 | $48,024 | $6,506 | 13.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 15 | 16 | $4,336 | $1,082 | 24.9% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 45 | 48 | $3,600 | $870.98 | 24.2% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 16 | 21 | $2,850 | $760.90 | 26.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 14 | 16 | $1,088 | $261.11 | 24.0% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 220 | 3,723 | $5.6M | $2.7M | 47.8% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2022 | 208 | 25,867 | $1.3M | $763,127 | 58.9% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 1,863 | 6,493 | $2.1M | $587,078 | 28.2% |
| 67028 | Injection of drug into eye | Office | 2022 | 551 | 4,233 | $2.3M | $401,539 | 17.7% |
| 92134 | Imaging of retina | Office | 2022 | 1,930 | 5,412 | $625,008 | $160,100 | 25.6% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 359 | 1,803 | $270,450 | $97,704 | 36.1% |
About Dr. Jawad Qureshi, MD
Dr. Jawad Qureshi, MD is a Ophthalmology healthcare provider based in Southlake, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811926769.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jawad Qureshi, MD has received a total of $4,082 in payments from pharmaceutical and medical device companies, with $625.84 received in 2024. These payments were reported across 67 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,605).
As a Medicare-enrolled provider, Qureshi has provided services to 25,251 Medicare beneficiaries, totaling 282,995 services with total Medicare billing of $18.7M. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Southlake, TX
- Active Since 07/02/2006
- Last Updated 10/09/2023
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1811926769
Products in Payments
- Indigo System (Device) $1,650
- OZURDEX (Drug) $260.16
- MVP (Device) $256.12
- EYLEA (Biological) $162.56
- Lucentis (Biological) $162.12
- Vabysmo (Drug) $158.06
- Syfovre (Drug) $157.96
- Perclose ProGlide suture mediated closure system (Device) $145.48
- ACTIVEFOCUS (Device) $145.14
- EYLEA HD (Biological) $144.66
- California (Device) $122.74
- INVELTYS (Drug) $109.72
- Cimerli (Biological) $71.35
- ACTHAR (Biological) $65.66
- YUTIQ (Drug) $51.88
- PROKERA (Device) $46.44
- BROLUCIZUMAB (Drug) $45.93
- Izervay (Drug) $33.17
- Iluvien (Biological) $28.63
- Avenova (Device) $24.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Southlake
Musa Abdelaziz, Md, MD
Ophthalmology — Payments: $3,627
Ophthalmology $3,627
Dr. Martin Reinke, M.d, M.D
Ophthalmology — Payments: $3,559
Ophthalmology $3,559
Luv Patel, M.d, M.D
Ophthalmology — Payments: $3,529
Ophthalmology $3,529
Omar Moinuddin, Md, MD
Ophthalmology — Payments: $3,193
Ophthalmology $3,193
Dr. Robert Lyons, Md, MD
Ophthalmology — Payments: $641.45
Ophthalmology $641.45